(Q37821918)

23 August 2017

1 reference

title

Hypertension in aging patients (English)

1 reference

23 August 2017

arterial hypertension

0 references

author name string

Alexander G Logan

series ordinal

1

1 reference

23 August 2017

1 January 2011

1 reference

Expert Review of Cardiovascular Therapy

23 August 2017

1 reference

23 August 2017

9

1 reference

23 August 2017

1

1 reference

23 August 2017

113-120

1 reference

Results of the Ontario survey on the prevalence and control of hypertension

23 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Blood pressure and cardiovascular disease in the Asia Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Blood pressure and survival in the oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Expert consensus document on arterial stiffness: methodological issues and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Hypertension and chronic kidney disease in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

From theory into practice: arterial haemodynamics in clinical hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

New algorithm for the diagnosis of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Ambulatory blood-pressure monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Factors influencing white-coat effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Multiple biomarkers for the prediction of first major cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Obesity in the elderly: who should we be treating, and why, and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Aerobic exercise training does not modify large-artery compliance in isolated systolic hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the pressure-natriuresis relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Double-blind randomised trial of modest salt restriction in older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Systematic review of long term effects of advice to reduce dietary salt in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Treatment of hypertension in patients 80 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Managing hypertension in the very elderly: effect of adverse drug reactions (ADRs) on achieving targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

The role of diastolic blood pressure when treating isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

On-treatment diastolic blood pressure and prognosis in systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Telmisartan to prevent recurrent stroke and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Feasibility of treating prehypertension with an angiotensin-receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Validity of the Framingham point scores in the elderly: Results from the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Aggressive lowering of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.171

21 January 2018

Identifiers

DOI

10.1586/ERC.10.171

1 reference

23 August 2017

1 reference

PubMed ID

21166533